Axio BioPharma

We’re excited to announce that several members of the Chemical Angel Network (CAN) have joined us as investors. Their support helps us continue our mission to accelerate life-saving biologics to the patients who need them most. If you’re interested in exploring ways to collaborate or partner, we’d love to hear from you! https://lnkd.in/gz3QgttK

?? What’s slowing down biologics development? ? Long lead times ? Unscalable workflows ? Inefficient data use At Axio BioPharma, we’re solving these problems with a data-driven approach to antibody manufacturing. ? Faster timelines ?? AI-powered process insights ?? Scalable, parallel workflows We’re not just accelerating drug development—we’re redefining it. If you're ready for faster, more reliable antibody production, let’s talk: https://lnkd.in/gz3QgttK #AIinBiopharma #Biomanufacturing #FasterAntibodies #CDMO #Biotech

?? How can AI reshape biomanufacturing? In this WisBusiness.com podcast, Axio BioPharma’s Justin Byers dives into how we're accelerating biologics development from years to hours. Traditional process development is slow and costly but at Axio we are accelerating development cycles by integrating AI-driven predictive modeling. This approach uses real-world data to build a scalable model that predicts clinical-ready processes, making biologics manufacturing faster, more efficient, and cost-effective. ?? If your company is navigating long timelines for process development, let's connect. ?? Listen to the full episode here: https://lnkd.in/gEQGNp9E ?? Book a meeting with Justin: https://lnkd.in/gy4J9YkX #biopharma #biomanufacturing #AI #drugdevelopment #startups #pharma #lifesciences #biotech

Axio BioPharma is hiring a Business Development Manager with Biologics CDMO sales experience. If you have a strong network in biopharma and experience in antibody production and manufacturing services, reach out or apply today! #Hiring #Biologics #CDMO #Biopharma

We had a great time at the BIO CEO & Investor Conference this week! It was fantastic connecting with industry leaders, investors, and innovators who are shaping the future of biopharma. From insightful discussions on regulatory policy to conversations about accelerating drug development, this event highlighted the power of collaboration in driving innovation. If we didn’t have a chance to connect during the event, reach out to connect with us: https://lnkd.in/gz3QgttK. Looking forward to what’s ahead! #BIOCEOInvestor #Biopharma #DrugDevelopment #AxioBioPharma #Innovation

Great first day at the BIO CEO & Investor Conference representing Axio BioPharma! Exciting discussions on the future of biopharma and connecting with industry leaders. Right now at the fireside chat with Nauman Shah, MBA, Global Head of Business Development at Johnson & Johnson Innovative Medicine, moderated by Drew Armstrong from Endpoints News. I’m looking forward to their insights on biopharma industry. Excited for what’s ahead! #BIOCEO #Biopharma #DrugDevelopment #AxioBioPharma

Next week, the BIO CEO & Investor Conference kicks off in New York, and our CEO, Justin Byers, will be there connecting with investors and industry leaders. He’ll be discussing how Axio BioPharma is advancing AI-driven biomanufacturing and accelerating biologics development. If you’re attending and want to connect, reach out to schedule a meeting! https://lnkd.in/gz3QgttK #BIOCEO2025 #Biomanufacturing #AI #Biotech #Investing

Hard to believe #JPM2025 is already over. The week was full of great meetings with amazing leaders in healthcare and biopharma. Let’s keep the conversations and collaborations going! Axio BioPharma is here to help you accelerate your next project with fast, reliable antibody manufacturing and AI-driven process development. We are excited about what’s in store for 2025 and look forward to working with innovators to bring life-saving therapies to patients faster. Let’s make it happen together! ?? Book a meeting with us today: https://lnkd.in/gSvXKc8b #Biopharma #AntibodyDevelopment #DrugDevelopment #AI #Innovation #Collaboration

We are proud to partner with eMBR Genomics to manufacture and distribute their MKLP1 Pro? antibodies. Together we are accelerating midbody remnant research and enabling critical discoveries! #Partnership #LifeSciences #AntibodyProduction #MBR

Lots of great conversations at the #AI Networking Showcase during #JPM2025, hosted by Katalyze AI! Leaders like Justin Byers, Reza Farahani, and Roman Gelman explored how AI is revolutionizing biomanufacturing by accelerating timelines, cutting costs, and making life-saving therapies more accessible. The future of biomanufacturing is here and we are excited to be part of it! #JPM2025 #Biomanufacturing #AI #BioTech #Healthcare #Innovation